Kevin Friedman is the founder of Kelonia Therapeutics. Kelonia Therapeutics has raised $50M, latest Series A $50M (2022). Biotech · Boston, MA.
Kevin Friedman is the founder of Kelonia Therapeutics. Kelonia Therapeutics operates in Biotech and is based in Boston, MA. Kelonia Therapeutics has raised $50M, latest Series A $50M (2022). Backers on record include Brian Ascher, Venrock.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Boston — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library